S&P 500   3,220.40 (-0.17%)
DOW   27,955.75 (-0.02%)
QQQ   221.52 (+0.06%)
AAPL   299.56 (+0.46%)
FB   202.18 (+0.73%)
MSFT   173.07 (+1.28%)
GOOGL   1,427.65 (+0.55%)
AMZN   2,011.90 (+0.13%)
CGC   20.24 (-0.30%)
BABA   208.40 (+1.09%)
MU   53.85 (-2.11%)
TSLA   826.54 (-0.87%)
AMD   49.08 (-0.08%)
T   38.19 (+0.37%)
ACB   1.56 (+0.65%)
F   7.52 (-0.66%)
NFLX   368.84 (+0.04%)
PRI   125.83 (-0.90%)
DIS   132.01 (-0.75%)
GILD   70.89 (-2.76%)
S&P 500   3,220.40 (-0.17%)
DOW   27,955.75 (-0.02%)
QQQ   221.52 (+0.06%)
AAPL   299.56 (+0.46%)
FB   202.18 (+0.73%)
MSFT   173.07 (+1.28%)
GOOGL   1,427.65 (+0.55%)
AMZN   2,011.90 (+0.13%)
CGC   20.24 (-0.30%)
BABA   208.40 (+1.09%)
MU   53.85 (-2.11%)
TSLA   826.54 (-0.87%)
AMD   49.08 (-0.08%)
T   38.19 (+0.37%)
ACB   1.56 (+0.65%)
F   7.52 (-0.66%)
NFLX   368.84 (+0.04%)
PRI   125.83 (-0.90%)
DIS   132.01 (-0.75%)
GILD   70.89 (-2.76%)
S&P 500   3,220.40 (-0.17%)
DOW   27,955.75 (-0.02%)
QQQ   221.52 (+0.06%)
AAPL   299.56 (+0.46%)
FB   202.18 (+0.73%)
MSFT   173.07 (+1.28%)
GOOGL   1,427.65 (+0.55%)
AMZN   2,011.90 (+0.13%)
CGC   20.24 (-0.30%)
BABA   208.40 (+1.09%)
MU   53.85 (-2.11%)
TSLA   826.54 (-0.87%)
AMD   49.08 (-0.08%)
T   38.19 (+0.37%)
ACB   1.56 (+0.65%)
F   7.52 (-0.66%)
NFLX   368.84 (+0.04%)
PRI   125.83 (-0.90%)
DIS   132.01 (-0.75%)
GILD   70.89 (-2.76%)
S&P 500   3,220.40 (-0.17%)
DOW   27,955.75 (-0.02%)
QQQ   221.52 (+0.06%)
AAPL   299.56 (+0.46%)
FB   202.18 (+0.73%)
MSFT   173.07 (+1.28%)
GOOGL   1,427.65 (+0.55%)
AMZN   2,011.90 (+0.13%)
CGC   20.24 (-0.30%)
BABA   208.40 (+1.09%)
MU   53.85 (-2.11%)
TSLA   826.54 (-0.87%)
AMD   49.08 (-0.08%)
T   38.19 (+0.37%)
ACB   1.56 (+0.65%)
F   7.52 (-0.66%)
NFLX   368.84 (+0.04%)
PRI   125.83 (-0.90%)
DIS   132.01 (-0.75%)
GILD   70.89 (-2.76%)
Log in

NYSEAMERICAN:INFU - InfuSystem Stock Price, Forecast & News

$10.95
+0.02 (+0.18 %)
(As of 02/25/2020 10:20 AM ET)
Today's Range
$10.90
Now: $10.95
$10.99
50-Day Range N/A
52-Week Range
$3.90
Now: $10.95
$11.89
Volume4,821 shs
Average Volume86,982 shs
Market Capitalization$217.34 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees237
Market Cap$217.34 million
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.


InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

How will InfuSystem's stock buyback program work?

InfuSystem announced that its board has authorized a share repurchase program on Tuesday, March 13th 2018, which authorizes the company to buyback 1,000,000 shares, according to EventVestor. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company's management believes its shares are undervalued.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) posted its earnings results on Monday, December, 12th. The medical instruments supplier reported $0.00 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $17.23 million for the quarter. View InfuSystem's Earnings History.

When is InfuSystem's next earnings date?

InfuSystem is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for InfuSystem.

Has InfuSystem been receiving favorable news coverage?

Media coverage about INFU stock has trended neutral this week, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. InfuSystem earned a news sentiment score of 0.0 on InfoTrie's scale. They also gave headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for InfuSystem.

Are investors shorting InfuSystem?

InfuSystem saw a increase in short interest in January. As of January 31st, there was short interest totalling 21,300 shares, an increase of 12.7% from the January 15th total of 18,900 shares. Based on an average daily trading volume, of 49,700 shares, the short-interest ratio is currently 0.4 days. Approximately 0.1% of the shares of the stock are sold short. View InfuSystem's Current Options Chain.

Who are some of InfuSystem's key competitors?

What other stocks do shareholders of InfuSystem own?

Who are InfuSystem's key executives?

InfuSystem's management team includes the folowing people:
  • Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
  • Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
  • Mr. Thomas Mark Ruiz, Sr. VP of Sales & Marketing
  • Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
  • Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Minerva Advisors LLC (10.48%), Renaissance Technologies LLC (1.90%), Gabelli Funds LLC (1.31%), Parkman Healthcare Partners LLC (0.63%), EAM Investors LLC (0.54%) and Punch & Associates Investment Management Inc. (0.41%). Company insiders that own InfuSystem stock include Awm Investment Company, Inc, Christopher R Sansone, David C Dreyer, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Scott Shuda and Terry L Armstrong. View Institutional Ownership Trends for InfuSystem.

Which major investors are selling InfuSystem stock?

INFU stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Minerva Advisors LLC and UBS Group AG. View Insider Buying and Selling for InfuSystem.

Which major investors are buying InfuSystem stock?

INFU stock was acquired by a variety of institutional investors in the last quarter, including Parkman Healthcare Partners LLC, EAM Investors LLC, FMR LLC, Renaissance Technologies LLC, Credit Suisse AG, Alambic Investment Management L.P., Geode Capital Management LLC and Acadian Asset Management LLC. Company insiders that have bought InfuSystem stock in the last two years include Awm Investment Company, Inc, Christopher R Sansone, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Scott Shuda and Terry L Armstrong. View Insider Buying and Selling for InfuSystem.

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $10.93.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $216.88 million. InfuSystem employs 237 workers across the globe.View Additional Information About InfuSystem.

What is InfuSystem's official website?

The official website for InfuSystem is http://ir.infusystem.com/.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.


MarketBeat Community Rating for InfuSystem (NYSEAMERICAN INFU)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  76 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  166
MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe INFU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INFU will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel